AI assistant
PENSANA PLC Proxy Solicitation & Information Statement 2026
5040_rns_2026-02-10_ba52d94b-e61b-4bc6-a17c-afef1d80e4be.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to what action you should take, you are advised to consult your own stockbroker, solicitor, accountant or other professional adviser authorised under the Financial Services and Markets Act 2000 immediately.
If you have sold or otherwise transferred all of your shares in Pensana Plc, please pass this document, together with the accompanying documents, to the purchaser or transferee, or to the person through whom the sale or transfer was effected for transmission to the purchaser or transferee.
Subject to passing of the Resolutions at the General Meeting, it is anticipated that admission to trading of the Subscription Shares will become effective and that dealings in the Subscription Shares will commence on the London Stock Exchange at 8 a.m. at or around 16 March 2026. Each of the Subscription Shares will rank pari passu with the Company's existing ordinary shares.
Pensana Plc
(incorporated and registered in England and Wales under the Companies Act 2006 and registered with number 12206525)
Notice of General Meeting
Your attention is drawn to the letter from the Chairman of the Company set out in this Document, which recommends that you vote in favour of the Resolutions to be proposed at the General Meeting referred to below.
Notice of a General Meeting of Pensana plc, to be held at Simmons & Simmons LLP, CityPoint, 1 Ropemaker Street, London, EC2Y 9SS on 9 March 2026 at 10 a.m., is set out at the end of this Document.
Dear Shareholder
10 February 2026
General Meeting to be held on 9 March 2026
I am pleased to inform you that a general meeting of the Company's shareholders (the "Shareholders") (the "General Meeting" or the "Meeting") will be held on 9 March 2026 at 10 a.m. at the offices of Simmons & Simmons LLP, CityPoint, 1 Ropemaker Street, London, EC2Y 9SS. The formal notice convening the General Meeting (the "Notice of General Meeting" or "Notice") is set out on pages 3 to 5 of this document.
BACKGROUND TO THE MEETING
On 9 December 2025, the Company announced a US$100 million subscription by a strategic investor in support of the Company's U.S. Mine-to-Magnet strategy (the "Initial Subscription"). The strategic investor is Cascade Natural Resources Limited and its associated companies ("Cascade"). Cascade is an investment platform focused on building a global portfolio of rare earth assets. Under the Initial Subscription, Cascade agreed to subscribe for 95,000,000 new ordinary shares of £0.001 each in the Company, subject to confirmatory due diligence of the Longonjo project along with shareholder authorisation of the issue of the 95,000,000 Ordinary Shares and approval of the allotment of the shares.
Cascade continues to progress its diligence and has presented the Company with a revised conditional subscription proposal of US$160 million (the "Subscription") in terms of which Cascade will subscribe for up to 144,508,671 new ordinary shares of £0.001 each in the Company ("Ordinary Shares"), subject to shareholder authorisation for the issue of up to 144,508,671 Ordinary Shares (the "New Shares") and approval of the allotment of the New Shares. Although Cascade may by agreement with the Company partly invest directly at subsidiary level, the Directors wish to obtain the authorities more fully set out in this Notice.
The Directors do not currently have sufficient authority and power to allot and issue the New Shares under the Companies Act 2006. Accordingly, the Directors are seeking the approval of Shareholders at the General Meeting to allot the New Shares, together with approval to disapply statutory pre-emption rights in respect of the issue of the New Shares.
In addition, as a result of the new maximum enlarged issued share capital of the Company, assuming that the issue and allotment of the New Shares takes place, the Directors are seeking to replace the Company's existing share authorities and pre-emption rights disapplications which were approved at the Company's annual general meeting on 3 December 2025 with new authorities based on the new maximum enlarged issued share capital of the Company. Further explanation of the resolutions to be proposed at the Meeting (the "Resolutions") is set out in the Explanatory Notes to the Notice.
RECOMMENDATION
The Directors believe that the proposals to be considered at the Meeting are in the best interests of both the Company and its shareholders. Accordingly, the Directors unanimously recommend that you vote in favour of the Resolutions as they intend to do in respect of their own beneficial holdings.
ATTENDANCE AND APPOINTING A PROXY
Your participation at the Meeting is important to your Board of Directors. If you are unable to attend the Meeting and you wish to vote on the Resolutions, you should appoint a proxy to exercise all or any of your rights, to attend, speak and vote at the Meeting. The completion of a form of proxy will not preclude you from attending the Meeting and voting in person if you so wish. Details of how to appoint a proxy are set out on pages 6 to 7 of this document.
Paul Atherley (Chairman)
NOTICE OF GENERAL MEETING
NOTICE IS HEREBY GIVEN that a general meeting of the shareholders (the "Meeting") of Pensana Plc (the "Company") will be held at the offices of Simmons & Simmons LLP, CityPoint, 1 Ropemaker Street, London, EC2Y 9SS at 10 a.m. on 9 March 2026 to consider and pass the resolutions below. Resolutions 1 and 2 (inclusive) will be proposed as ordinary resolutions and resolutions 3 to 5 (inclusive) will be proposed as special resolutions.
ORDINARY RESOLUTIONS
Resolution 1 That the directors of the Company (the "Directors") be generally and unconditionally authorised in accordance with section 551 of the Companies Act 2006 (the "Act") to exercise all the powers of the Company to allot ordinary shares in the Company up to an aggregate nominal amount of £144,509.00 pursuant to the Subscription (as defined and set out in the circular to shareholders of the Company to which this Notice of General Meeting is included) and for no other purpose provided that this authority shall expire at the conclusion of the next annual general meeting of the Company or if earlier, at the close of business on 31 December 2026 (unless previously renewed, varied or revoked by the Company), in each case, so that the Company may, before such expiry, make an offer or agreement which would or might require shares to be allotted after such expiry and the Directors may allot shares pursuant to such an offer or agreement as if this authority had not expired.
Resolution 2 That, in substitution for all other powers granted to the Directors at the annual general meeting of the Company held on 3 December 2025 and conditional upon the passing of Resolution 1, the Directors be generally and unconditionally authorised in accordance with section 551 of the Companies Act 2006 (the "Act") to exercise all the powers of the Company:
(a) to allot ordinary shares in the Company and to grant rights to subscribe for or to convert any security into ordinary shares in the Company, up to an aggregate nominal amount of £161,343.79; and
(b) to allot ordinary shares in the Company and to grant rights to subscribe for or to convert any security into ordinary shares in the Company comprising equity securities (within the meaning of section 560(1) of the Act) up to an aggregate nominal amount of £322,689.57 (such amount to be reduced by the aggregate nominal amount of any ordinary shares allotted or rights granted under paragraph (a) above) in connection with an offer of equity securities (including, without limitation, under a rights issue, open offer or similar arrangement) in favour of:
i. ordinary shareholders in proportion (as nearly as may be practicable) to the respective number of shares held by them; and
ii. holders of other equity securities if this is required by the rights of those securities or, subject to such rights, as the Directors consider necessary,
subject in both cases to the power of the Directors to impose any limits or restrictions and make any arrangements which they consider necessary or appropriate to deal with treasury shares, fractional entitlements, record dates or legal, regulatory or practical problems in, or under the laws of, any territory or any other matter and provided that this authority shall expire at the conclusion of the next annual general meeting of the Company or if earlier, at the close of business on 31 December 2026 (unless previously renewed, varied or revoked by the Company), in each case, so that the Company may, before such expiry, make an offer or agreement which would or might require shares to be allotted or rights to subscribe for or convert securities into shares to be granted after such expiry and the Directors may allot shares or grant rights to subscribe for or convert securities into shares pursuant to such an offer or agreement as if this authority had not expired.
3
SPECIAL RESOLUTIONS
Resolution 3
That, subject to and conditional on the passing of resolution 1, the Directors be authorised, pursuant to section 570 of the Act, to allot equity securities (within the meaning of section 560(1) of the Act) for cash pursuant to the authority conferred by resolution 1 as if section 561 of the Act did not apply to any such allotment, provided that such power is limited to the allotment of equity securities up to an aggregate nominal amount of £144,509.00 in connection with the Subscription (as defined and set out in the circular to shareholders of the Company to which this Notice of General Meeting is included) and for no other purpose, such authority to expire at the conclusion of the next annual general meeting of the Company or, if earlier, at the close of business on 31 December 2026 (unless previously renewed, varied or revoked by the Company) but, in each case, before such expiry the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted after the authority expires and the Directors may allot equity securities under any such offer or agreement as if this authority had not expired.
Resolution 4
That, in substitution for all other authorities granted to the Directors at the annual general meeting of the Company held on 3 December 2025 and conditional upon the passing of resolution 2, the Directors be authorised, pursuant to section 570 of the Act, to allot equity securities (within the meaning of section 560(1) of the Act) for cash pursuant to the authority conferred by resolution 2 and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the Act did not apply to any such allotment or sale, provided that such power is limited to:
(a) the allotment of equity securities and sale of treasury shares for cash in connection with an offer of equity securities (including, without limitation, under a rights issue, open offer or similar arrangement) in favour of:
i. ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings; and
ii. holders of other equity securities as required by the rights of those securities or, subject to such rights, as the Directors otherwise consider necessary,
subject in both cases to the power of the Directors to impose any limits or restrictions and make any arrangements which they consider necessary or appropriate to deal with treasury shares, fractional entitlements, record dates or legal, regulatory or practical problems in, or under the laws of, any territory or any other matter;
(b) the allotment of equity securities or sale of treasury shares for cash (otherwise than under paragraph (a) above) up to an aggregate nominal amount of £48,304.14; and
(c) the allotment of equity securities or sale of treasury shares for cash (otherwise than under paragraph (a) or paragraph (b) above) up to a nominal amount equal to 20% of any allotment of securities or sale of treasury shares from time to time under paragraph (b) above, such authority to be used only for the purposes of making a follow-on offer which the Directors determine to be of a kind contemplated by paragraph 3 of Section 2B of the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this notice,
such authority to expire at the conclusion of the next annual general meeting of the Company or, if earlier, at the close of business on 31 December 2026 (unless previously renewed, varied or revoked by the Company) but, in each case, before
4
such expiry the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires and the Directors may allot equity securities (and sell treasury shares) under any such offer or agreement as if this authority had not expired.
Resolution 5
That, subject to and conditional on the passing of resolution 2, the Directors be authorised, pursuant to section 570 of the Act, in addition to the authority granted under resolution 4, to allot equity securities (within the meaning of section 560(1) of the Act) for cash pursuant to the authority conferred by resolution 2 and/or to sell ordinary shares held by the Company as treasury shares for cash as if section 561 of the Act did not apply to any such allotment or sale, provided that such power is limited to:
(a) the allotment of equity securities or sale of treasury shares for cash up to an aggregate nominal amount of £48,304.14, such authority to be used only for the purposes of financing (or refinancing, if the authority is to be used within 12 months after the original transaction) a transaction which the Directors determine to be either an acquisition or a specified capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this notice; and
(b) the allotment of equity securities or sale of treasury shares for cash (otherwise than under paragraph (a) above) up to a nominal amount equal to 20% of any allotment of securities or sale of treasury shares from time to time under paragraph (a) above, such authority to be used only for the purposes of making a follow-on offer which the Directors determine to be of a kind contemplated by paragraph 3 of Section 2B of the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this notice,
such authority to expire at the conclusion of the next annual general meeting of the Company or, if earlier, at the close of business on 31 December 2026 (unless previously renewed, varied or revoked by the Company) but, in each case, before such expiry the Company may make offers, and enter into agreements, which would, or might, require equity securities to be allotted (and treasury shares to be sold) after the authority expires and the Directors may allot equity securities (and sell treasury shares) under any such offer or agreement as if this authority had not expired.
By Order of the Board
St James's Corporate Services Limited
St James's Corporate Services Limited
Company Secretary
Pensana Plc
107 Cheapside
2nd Floor
London EC2N 6DN
10 February 2026
6
EXPLANATORY NOTES TO THE RESOLUTIONS
Resolutions 1 to 2 (inclusive) will be proposed as ordinary resolutions and resolutions 3 to 5 (inclusive) will be proposed as special resolutions.
Resolution 1 Allotment of Shares
The authority in Resolution 1 will allow the Directors to allot the shares required for the Subscription (the "Subscription Shares").
Resolution 2 Allotment of Shares
At the Annual General Meeting held on 3 December 2025, the Directors were given the authority to allot shares without the prior consent of shareholders for a period expiring at the conclusion of the next annual general meeting or, if earlier, 31 December 2026. This resolution, which is conditional upon the passing of Resolution 1, replicates the authority save that the amount is increased as a consequence of the allotment of the Subscription Shares.
The authority in Resolution 2 paragraph (a) will allow Directors to allot shares (including treasury shares) in the Company or grant rights to subscribe for, or convert any security into, shares in the Company, up to an aggregate nominal amount of £161,343.79, representing approximately one-third of the Company's issued ordinary share capital once the Subscription Shares have been allotted.
The authority in Resolution 2 paragraph (b) will allow Directors to allot shares or grant rights to subscribe for, or convert any security into, shares in the Company, only in connection with a fully pre-emptive offer of equity securities (including, without limitation, under a rights issue, open offer or similar arrangement) up to an aggregate nominal amount of £322,687.57, representing approximately two-thirds of the Company's issued ordinary share capital once the Subscriptions Shares have been issued as reduced by the nominal amount of any shares allotted under paragraph (a) of this Resolution. This is in line with the current institutional guidelines issued by the Investment Association.
The Directors have no present intention of exercising this authority but believe that the flexibility allowed by this Resolution may assist them in taking advantage of business opportunities as they arise.
As at 9 February 2026 (being the latest practicable date prior to the publication of this notice), the Company held no ordinary shares in treasury. The Directors intend to renew this authority annually.
Resolutions 3, 4 and 5 Disapplication of Pre-Emption Rights
Resolution 3 disapplies statutory pre-emption rights in relation to the allotment of the Subscription Shares. It means that the Directors do not need to first offer the Subscription Shares to existing shareholders in proportion to their holdings.
Resolutions 4 and 5 renew authorities granted at last year's Annual General Meeting held on 3 December 2025 and gives the Directors authority to allot any shares or grant rights over shares or sell treasury shares for cash (other than pursuant to an employee share scheme) without first offering them to existing shareholders in proportion to their holdings.
Resolution 4 authorises allotments or sales in connection with (i) pre-emptive offers (including, without limitation, under a rights issue, open offer or similar arrangement) and (ii) allotments of equity securities or sale of treasury shares for cash up to an aggregate nominal amount of £48,403.14 which represents ten per cent of the Company's issued share capital assuming that the Subscription Shares have been allotted plus an additional 20 per cent of any allotments or sales made under (ii) above (so a maximum of 2%), such power to be used only for the purposes of making a follow-on offer of a kind contemplated by Section 2B of the Statement of Principles on Disapplying Pre-Emption Rights (the "Pre-Emption Principles") most recently published by the Pre-Emption Group prior to the date of this notice.
Resolution 5 authorises allotments of equity securities or sale of treasury shares for cash, in addition to any authority granted under Resolution 4, up to an aggregate nominal amount of £48,403.14 (which represents ten per cent of the Company's issued share capital assuming that the Subscription Shares have been allotted plus an additional 20 per cent of any allotments or sales made under this authority (so a maximum of 2%), such power to be used only for the purposes of making a follow-on offer of a kind contemplated by Section 2B of the Pre-Emption Principles. This authority will only be used for the purposes of financing (or refinancing, if the authority is to be used within 12 months after the original transaction) a transaction which the Directors determines to be either an acquisition or a specified capital investment of a kind contemplated by the Pre-Emption Principles.
Although the Directors embrace the flexibility conferred by Resolutions 4 and 5 to issue shares without the application of pre-emption rights, the Directors also recognise that existing shareholders may be keen to participate in a non pre-emptive "follow-on" offer carried out under these authorities. The Directors are therefore supportive of the ability to make a "follow-on" offer as reflected in the Pre-Emption Principles, and such ability has been reflected in each of Resolution 4 and Resolution 5, as set out above. The Directors confirm that they intend to follow the shareholder protections and approach to follow-on offers contained in Part 2B of the Pre-Emption Principles.
Both authorities sought at the Meeting will expire at the conclusion of the next annual general meeting of the Company or, if earlier, at close of business on 31 December 2026.
7
8
NOTES TO THE NOTICE OF MEETING
Entitlement to vote
Only holders of Ordinary Shares entered on the Company's register of members at 10a.m. on 5 March 2026 (or in the event of an adjournment, on the date falling two (2) business days before the date of the adjourned meeting) or their proxies are entitled to notice of and to vote at the Meeting. Shareholders may cast votes only in respect of shares of which they were registered holders at such time, and changes to the register of members after the relevant deadline shall be disregarded in determining the rights of any person to vote at the Meeting.
Proxy appointments
Shareholders are entitled to appoint a proxy to exercise all or any of their rights to attend, speak and to vote on their behalf at the Meeting. A shareholder may appoint more than one proxy in relation to the Meeting provided that each proxy is appointed to exercise the rights attached to a different share or shares held by that shareholder. A proxy need not be a member of the Company.
A Proxy Form is enclosed with this notice and instructions for its completion are shown on the form. Shareholders may appoint a valid proxy by completing and depositing the enclosed proxy form at the offices of Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol BS99 6ZY or via email to #[email protected] with the original to follow when possible, by 10a.m. on 5 March 2026 or 48 business-day hours before any adjourned meeting.
You can also vote via the internet on Computershare's website by visiting investorcentre.co.uk/eproxy. You will be asked to enter the Control Number, your Shareholder Reference Number and your unique PIN, which are detailed on the accompanying Form of Proxy.
Alternatively, if you hold your shares through a nominee service, please contact your nominee service provider for instructions on how to vote.
A shareholder must inform the Company's registrars in writing of any termination of the authority of a Proxy.
CREST members who wish to appoint a Proxy or Proxies through the CREST electronic Proxy appointment service may do so for the Meeting to be held on 9 March 2026 (and any adjournment(s) thereof) by following the procedures described in the CREST Manual. CREST personal members or other CREST sponsored members (and those CREST members who have appointed a voting service provider(s)) should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf.
In order for a Proxy appointment made by means of CREST to be valid, the appropriate CREST message (a "CREST Proxy Instruction") must be properly authenticated in accordance with Euroclear UK & International Limited ("EUI")'s specifications and must contain the information required for such instructions, as described in the CREST Manual (available via www.euroclear.com/CREST). The message (regardless of whether it constitutes the appointment of a Proxy or an amendment to the instruction given to a previously appointed Proxy) must, in order to be valid, be transmitted so as to be received by the issuer's agent (ID 3RA50) by the latest time(s) for receipt of Proxy appointments specified in the notice of Meeting. For this purpose, the time of receipt will be taken to be the time (as determined by the time-stamp applied to the message by the CREST Applications Host) from which the issuer's agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. After this time any change of instructions to a Proxy appointed through CREST should be communicated to him by other means.
CREST members (and, where applicable, their CREST sponsors or voting service provider(s)) should note that EUI does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider(s), to procure that
his CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members (and, where applicable, their CREST sponsors or voting service provider(s)) are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings.
The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in regulation 35(5)(a) of the Uncertificated Securities Regulations 2001, as amended.
In the case of a shareholder which is a Company, the proxy form must be executed under its common seal or signed on its behalf by an officer of the Company or an attorney for the Company.
Any power of attorney or any other authority under which the proxy form is signed (or a duly certified copy of such power or authority) must be included with the proxy form.
In the case of joint holders, where more than one of the joint holders purports to appoint a proxy, only the appointment submitted by the most senior holder will be accepted. Seniority is determined by the order in which the names of the joint holders appear in the Company's register of members in respect of the joint holding (the first-named being the most senior).
To change your proxy instructions simply submit a new proxy appointment using the methods set out above. Note that the cut-off time for receipt of proxy appointments (see above) also applies in relation to amended instructions. Any amended proxy appointment received after the relevant cut-off time will be disregarded.
Where you have appointed a proxy using the hard-copy proxy form and would like to change the instructions using another hard-copy proxy form, please contact Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol BS99 6ZY.
If you submit more than one valid proxy appointment, the appointment received last before the latest time for the receipt of proxies will take precedence.
In order to revoke a proxy instruction, you will need to inform the Registrar by sending a signed hard-copy notice clearly stating your intention to revoke your proxy appointment as above. In the case of a member which is a Company, the revocation notice must be executed under its common seal or signed on its behalf by an officer of the Company or an attorney for the Company.
Any power of attorney or any other authority under which the revocation notice is signed (or a duly certified copy of such power or authority) must be included with the revocation notice.
The revocation notice must be received by Computershare Investor Services PLC The Pavilions, Bridgwater Road, Bristol BS99 6ZY or via email to #[email protected] no later than 10a.m. on 5 March 2026. If you attempt to revoke your proxy appointment but the revocation is received after the time specified then, subject to the paragraph directly below, your proxy appointment will remain valid.
Completing a proxy form does not prevent a shareholder from attending and voting in person. However, if the United Kingdom government's guidance on social distancing changes, proxies other than the chair of the Meeting may be prevented from attending the Meeting in person, therefore shareholders appointing a proxy are strongly encouraged to appoint the chair of the Meeting to be their proxy in order that their proxy vote can be counted.
Nominated Persons
Any person to whom this notice is sent who is a person nominated under section 146 of the Companies Act 2006 to enjoy information rights (a "Nominated Person") may, under an agreement between him/her and the shareholder by whom he/she was nominated, have a right to be appointed (or to have someone else appointed) as a proxy for the Meeting. If a Nominated Person has no such proxy appointment right or does not wish to exercise it, he/she may, under any such agreement, have a right to give instructions to the shareholder as to the exercise of voting rights.
9
The statements of the rights of shareholders in relation to the appointment of proxies in this notice do not apply to a Nominated Person. The rights of shareholders in relation to the appointment of proxies can only be exercised by registered shareholders of the Company. Nominated Persons are reminded that they should contact the registered holder of their shares (and not the Company) on matters relating to their investments in the Company.
Voting at meeting
In accordance with the Company's established practice, the resolution will be taken on a poll so as to accurately record the decision of all shareholders based on their shareholding interests in the Company.
Corporate representatives
Any corporation, which is a shareholder, can appoint one or more corporate representatives who may exercise on its behalf of all its powers as a shareholder provided that they do not do so in relation to the same shares.
Total voting rights
As at 9 February 2026 (being the last practicable date prior to any publication of this notice) the Company's issued share capital consists of 339,522,689 Ordinary Shares, carrying one vote each. The total voting rights in the Company as at 9 February 2026 are, therefore 339,522,689.
Right to ask questions at the Meeting
During the meeting, there will be an opportunity for shareholders, proxies or corporate representatives to ask questions relevant to the business of the meeting.
Documents available for inspection
The following documents, which are available for inspection during normal business hours at the registered office of the Company on any weekday (Saturdays, Sundays and public holidays excluded), will also be available for inspection at the place of the Meeting from 9a.m. on the day of the Meeting until the conclusion of the Meeting:
(a) copies of the service contracts of the Executive Directors under which they are employed by the Company and the letters of appointment (and other related documents) of the Non-Executive Directors; and
(b) the Articles of Association of the Company.
A copy of this notice, and other information required by section 311A of the Act, can be found on the Company's website (www.pensana.co.uk).
You may not use any electronic address provided either in this notice or in any related documents (including the Proxy Form) to communicate with the Company for any purposes other than those expressly stated.
10